208
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Performance of a Predictive Model versus Prescription-Based Thresholds in Identifying Patients at Risk of Fatal Opioid Overdose

ORCID Icon, , , , , , , & show all

References

  • Bohnert, A. S., Logan, J. E., Ganoczy, D., & Dowell, D. (2016). A detailed exploration into the association of prescribed opioid dosage and overdose deaths among patients with chronic pain. Medical Care, 54(5), 435–441.
  • Boscarino, J. A., Kirchner, H. L., Pitcavage, J. M., Nadipelli, V. R., Ronquest, N. A., Fitzpatrick, M. H., & Han, J. J. (2016). Factors associated with opioid overdose: A 10-year retrospective study of patients in a large integrated health care system. Substance Abuse and Rehabilitation, 7, 131–141. https://doi.org/10.2147/SAR.S108302
  • Centers for Disease Control and Prevention. (2018). Quality improvement and care coordination: Implementing the CDC guideline for prescribing opioids for chronic pain.
  • Dowell, D., Haegerich, T. M., & Chou, R. (2016). CDC guideline for prescribing opioids for chronic pain — United States, 2016. MMWR. Recommendations and Reports: Morbidity and Mortality Weekly Report. Recommendations and Reports, 65(1), 1–49. https://doi.org/10.15585/mmwr.rr6501e1
  • Ferris, L. M., Saloner, B., & Krawczyk, N. (2019). Predicting opioid overdose deaths using prescription drug monitoring program data. American Journal of Preventive Medicine, 57(6), e211–e217.
  • Geissert, P., Hallvik, S., Van Otterloo, J., Oʼkane, N., Alley, L., Carson, J., Leichtling, G., Hildebran, C., Wakeland, W., & Deyo, R. A. (2018). High-risk prescribing and opioid overdose: Prospects for prescription drug monitoring program-based proactive alerts. Pain, 159(1), 150–156. https://doi.org/10.1097/j.pain.0000000000001078
  • Glanz, J. M., Narwaney, K. J., Mueller, S. R., Gardner, E. M., Calcaterra, S. L., Xu, S., Breslin, K., & Binswanger, I. A. (2018). Prediction model for two-year risk of opioid overdose among patients prescribed chronic opioid therapy. Journal of General Internal Medicine, 33(10), 1646–1653. https://doi.org/10.1007/s11606-017-4288-3
  • Gonzalez, A. M., & Kolbasovsky, A. (2012). Impact of a managed controlled-opioid prescription monitoring program on care coordination. The American Journal of Managed Care, 18(9), 516–524.
  • Gudoski, A. J. (2015). Prescription drug monitoring programs: Combating prescription drug misuse. The Nurse Practitioner, 40(11), 28–33. https://doi.org/10.1097/01.NPR.0000472247.21080.fc
  • Liang, Y., Goros, M. W., & Turner, B. J. (2016). Drug overdose: Differing risk models for women and men among opioid users with non-cancer pain. Pain Medicine, 17(12), 2268–2279. https://doi.org/10.1093/pm/pnw071
  • Liang, Y., & Turner, B. J. (2015). Assessing risk for drug overdose in a national cohort: Role for both daily and total opioid dose? The Journal of Pain, 16(4), 318–325. https://doi.org/10.1016/j.jpain.2014.11.007
  • Maryland Department of Health. Office of the Chief Medical Examiner. https://health.maryland.gov/ocme/Pages/Home.aspx
  • Oliva, E. M., Bowe, T., Tavakoli, S., Martins, S., Lewis, E. T., Paik, M., Wiechers, I., Henderson, P., Harvey, M., Avoundjian, T., Medhanie, A., & Trafton, J. A. (2017). Development and applications of the veterans health administration's stratification tool for opioid risk mitigation (STORM) to improve opioid safety and prevent overdose and suicide. Psychological Services, 14(1), 34–49. https://doi.org/10.1037/ser0000099
  • Paulozzi, L. J., Kilbourne, E. M., Shah, N. G., Nolte, K. B., Desai, H. A., Landen, M. G., Harvey, W., & Loring, L. D. (2012). A history of being prescribed controlled substances and risk of drug overdose death. Pain Medicine (Malden, Mass.), 13(1), 87–95. https://doi.org/10.1111/j.1526-4637.2011.01260.x
  • Picard, R. R. (1990). BK. Data splitting. American Statistician, 44(2), 140–147.
  • Prescription Drug Monitoring Program (PDMP) Center of Excellence at Brandeis. (2018 March). History of prescription drug monitoring programs. https://www.pdmpassist.org/pdf/PDMP_admin/TAG_History_PDMPs_final_20180314.pdf
  • Prescription Drug Monitoring Program (PDMP) Center of Excellence at Brandeis. (2019 February). Questionnaire results from state PDMP programs sent by PDMP TTAC for the purposes of this analysis.
  • Prescription Drug Monitoring Program (PDMP) Center of Excellence at Brandeis. (2019 August). Engaged in sending solicited and unsolicited reports to prescribers. https://www.pdmpassist.org/pdf/Prescribers_Sol_Unsol_Reports_20190816.pdf
  • Simeone, R. H. (2006). An evaluation of prescription drug monitoring programs. Washington, DC: U.S. Department of Justice, Office of Justice Programs. Simeone Associates, Inc. Available at: http://media.timesfreepress.com/docs/2008/03/Federal_prescription_monitoring_report.pdf
  • Sorg, M. H., LaBrie, S., & Parker, W. (2009). Analysis and evaluation of participation by prescibers and dispensers in the maine state prescription monitoring program. Anthropology Faculty Scholarship, 19. Available at: http://mcspolicycenter.umaine.edu/files/pdf/PMP%20Report%20Final%20Nov09.pdf
  • Young, L. D., Kreiner, P. W., & Panas, L. (2017). Unsolicited reporting to prescribers of opioid analgesics by a state prescription drug monitoring program: An observational study with matched comparison group. Pain Medicine, 1–12.
  • Zedler, B., Saunders, W. B., Joyce, A. R., Vick, C. C., & Murrelle, E. L. (2018). Validation of a screening risk index for serious prescription opioid-induced respiratory depression or overdose in a US commercial health plan claims database. Pain Medicine (Malden, Mass.), 19(1), 68–78. https://doi.org/10.1093/pm/pnx009
  • Zedler, B., Xie, L., Wang, L., Joyce, A., Vick, C., Brigham, J., Kariburyo, F., Baser, O., & Murrelle, L. (2015). Development of a risk index for serious prescription opioid-induced respiratory depression or overdose in Veterans' Health Administration Patients. Pain Medicine (Malden, Mass.), 16(8), 1566–1579. https://doi.org/10.1111/pme.12777

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.